We are late pre-clinical stage oncology drug development company developing new revolutionary therapies against cancer and diabetes. We have a vision of changing cancer treatment, addressing resistance development, metastasis, and patient relapse. Felicitex owns proprietary sets of clinical candidates: selective and specific small molecule inhibitors.Principals have unique expertise in the development of cancer therapeutics, extensive Pharma and business development experience. Felicitex has developed multiple collaborations with leading academic and commercial institutions.
© 2019 by Felicitex Therapeutics, Inc »«